Doctor, please don’t take me off the cream—it’s the only thing that’s really worked for me…

 

Clinical presentation


Easy. Moderate frequency.

A 52-year-old patient has had facial lesions for about eight months; they began as small papules and pustules.

The patient had tried several topical treatments, but obtained only temporary relief with a cream containing clobetasol 0.05%, initially prescribed for a foot problem. They have been applying it daily to the face for three months.

Despite this, the condition continues to worsen and is accompanied by an intense burning sensation.




Diagnosis: steroid-induced rosacea-like dermatitis or steroid rosacea.


Steroid rosacea

Prolonged application of potent topical corticosteroids to the face can cause a condition that mimics or worsens rosacea.

It may present with persistent erythema, burning, flushing, papules, pustules, or inflammatory plaques. In some patients, it follows a predominantly perioral, periocular, or perinasal pattern.

The corticosteroid initially reduces inflammation and provides rapid improvement. However, continued use leads to dependence, loss of efficacy, and progressive worsening.

Key point: the immediate relief produced by the corticosteroid may conceal the fact that, in the medium term, it is perpetuating and worsening the condition.

The cycle of dependence


1. Initial improvement

The corticosteroid rapidly reduces erythema and the burning sensation.

2. Rebound effect

When its use is reduced or stopped, vasodilation, burning, and a severe inflammatory flare develop.

3. Reapplication

The patient uses it again to relieve the flare, establishing a cycle of dependence.

```

Clues to recognition


Clinical feature What it suggests
Use of a potent corticosteroid on the face This is the key history finding.
Rapid but temporary improvement Encourages the patient to continue applying it.
Erythema, papules, and pustules Produces an appearance similar to inflammatory rosacea.
Intense burning or stinging Common, especially during the rebound effect.
Worsening after discontinuation Suggests corticosteroid-induced dependence and rebound.

Practical diagnosis

In any rosacea-like facial eruption, always ask what products the patient is applying and for which areas they were originally prescribed.


1
Ask

Review creams, ointments, and treatments used in recent months.

2
Link

Link onset or worsening to facial corticosteroid use.

3
Warn

Explain that temporary worsening may occur during withdrawal.

```

Management

The essential measure is to withdraw the topical corticosteroid. However, after prolonged use, abrupt discontinuation can trigger a very severe flare and prompt the patient to apply it again.

Corticosteroid withdrawal

  • Explain the possibility of a rebound effect in advance.
  • Taper gradually when use has been prolonged.
  • Avoid restarting the corticosteroid in response to temporary worsening.
  • A topical calcineurin inhibitor may be considered as bridging therapy.

Treatment of the rosacea-like inflammation

  • Topical metronidazole.
  • Topical ivermectin.
  • Topical azelaic acid.
  • Oral doxycycline in moderate or severe cases.

Take-home message

Potent topical corticosteroids should not be used continuously on the face. They may provide initial improvement, but can also cause dependence, rebound, and progressively more severe rosacea-like dermatitis.

Final summary

  • Cause: prolonged use of topical corticosteroids, especially high-potency agents, on the face.
  • Clinical features: erythema, burning, flushing, papules, pustules, or inflammatory plaques.
  • Main clue: temporary improvement with the corticosteroid and worsening after discontinuation.
  • Problem: a cycle of dependence and reapplication may develop.
  • Management: corticosteroid withdrawal, counselling about rebound, and specific treatment of the rosacea-like component.


When rosacea improves briefly with corticosteroids but subsequently worsens, consider steroid rosacea.

Comments

Post a Comment

Popular posts from this blog

Photoprotection and vitamin D: how can we sunbathe safely without falling short

Image
  Controversy Photoprotection and vitamin D: how can we sunbathe safely without falling short Photoprotection is one of the most important measures for preventing cumulative sun damage, premature skin aging, and skin cancer. But a reasonable question often comes up: if we protect ourselves a lot from the sun, can we develop vitamin D deficiency? The practical answer is that it is possible to maintain good photoprotection without giving up adequate vitamin D levels. The key is understanding that we do not need to burn, tan, or spend a long time exposed to the sun in order to synthesize vitamin D. Key point: the goal is not to avoid the sun at all costs, but to avoid sun damage. Exposure should be brief, gradual, adapted to skin phototype, and always avoid sunburn.
Read more

Which topical treatment should I choose for a patient with actinic keratoses?

Clinical question Which topical treatment should I choose for a patient with actinic keratoses? In patients with multiple actinic keratoses on photodamaged skin, the aim is to treat the field of cancerisation , not only the visible lesions. In practice, the choice usually comes down to 5-fluorouracil (5-FU), imiquimod and tirbanibulin. 5-FU is the reference option when efficacy and clinical experience are the priorities. Imiquimod is an established alternative. Tirbanibulin is particularly useful when a very short, well-tolerated course is needed. Before starting. Do not automatically treat a lesion that is indurated, painful, ulcerated, bleeding, markedly hyperkeratotic or clearly different. In these cases, Bowen disease or invasive squamous cell carcinoma should be excluded, and biopsy or referral considered. 1. 5-FU, imiquimod or tirbanibulin 5% 5-FU has the strongest comparative evidence at 12 months: in a direct trial it was more effective than imiquimod and also more cos...
Read more